Careful selection of psychotropic drugs with favorable pharmacokinetic and side effect profiles is necessary in elderly patients to minimize adverse events.
No takes yet. Share an insight, caveat, or question.
Supports cautious psychotropic selection in elderly patients; leaves open confirmation by randomized trials.
Andrew M. Barclay (1985) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: